Greco-Hainsworth Tennessee Oncology Centers for Research

Tennessee Oncology is one of the largest community-based oncology practices in the United States, providing comprehensive cancer care and extensive clinical research services. The organization's research division, historically known as the Greco-Hainsworth Tennessee Oncology Centers for Research, is a premier site for Phase 1 through Phase 3 clinical trials. Through a strategic partnership with the Sarah Cannon Research Institute, Tennessee Oncology offers patients early access to innovative therapeutic modalities, including targeted therapies, immunotherapies, and cellular treatments. Headquartered in Nashville, the practice operates over 30 locations across Tennessee and North Georgia, serving as a critical hub for oncology drug development and patient care.